drugset
drugset / Trial / NCT03748524

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

NCT03748524 ↗

Phase 0 Completed 11 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelBasic science

Summary

Immunization with the inactivated influenza vaccine with blood samples collected at 7 visits (baseline, day 7, 14, 28, 60, 90 and 180, fine needle aspiration (FNAs) from axillary lymph nodes at baseline, days, 4, 14, 28, 60 and 180. BMA at baseline, days 28 and 180.

Timeline

Start
2018-10-29
Primary completion
2021-09-30
Completion
2022-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine — Intramuscular

Indications

No indication recorded.